Inventor · disambiguated record
Emma Blackham
Also filed as: BLACKHAM EMMA
3 granted patents·6 pending applications·3 citations·filing 2018–2025
56Inventor score
Files withSTEP PHARMA S A S9
Top patents by PatentIndex Score
9 records- 0180US11987573B2Aminopyrimidine/pyrazine derivatives as CTPS1 inhibitorsSTEP PHARMA S A S·Filed 2019·Granted May 21, 2024·2 cites·5 claims
- 0273US11655246B2Aminothiazole compounds as inhibitors of CTPS1STEP PHARMA S A S·Filed 2018·Granted May 23, 2023·1 cites·19 claims
- 0370US2025282756A1Aminopyrimidine/pyrazine derivatives as CTPS1 inhibitorsSTEP PHARMA S A S·Filed 2025·Application pending·0 cites
- 0458US2023192673A1CompoundsSTEP PHARMA S A S·Filed 2022·Application pending·0 cites
- 0557US12466810B2N-(5-(6-ethoxypyrazin-2-yl)pyridin-2-yl)-4-(2-(methylsulfonamido)pyrimidin-4-yl) tetrahydro-2H-pyran-4-carboxamide derivatives and related compounds as human CTPS1 inhibitors for the treatment of proliferative diseasesSTEP PHARMA S A S·Filed 2020·Granted Nov 11, 2025·0 cites·5 claims
- 0649US2023020663A1Sulfonamide inhibitors as ctps1 inhibitorsSTEP PHARMA S A S·Filed 2020·Application pending·0 cites
- 0748US2023002352A1Sulfonamide derivatives as ctps1 inhibitorsSTEP PHARMA S A S·Filed 2020·Application pending·0 cites
- 0847US2023086703A1N-(4-(5-chloropyridin-3-yl)phenyl)-2-(2-(cyclopropanesulfonamido)pyrimidin-4-yl) butanamide derivatives and related compounds as human CTPS1 inhibitors for the treatment of proliferative diseasesSTEP PHARMA S A S·Filed 2020·Application pending·0 cites
- 0941US2021024507A1CompoundsSTEP PHARMA S A S·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Emma Blackham files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →